Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections
Gastroenterology - United Kingdom
doi 10.1053/j.gastro.2016.05.021
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2016
Authors
Publisher
Elsevier BV